Global Human Microbiome Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • ID:PD013308
  • July 2020
  • GIR (Global Info Research)
                          

The Global Human Microbiome Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.

The Human Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Human Microbiome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 20.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 590 million by 2025, from USD 284.5 million in 2019.

Market Segmentation
Human Microbiome market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Microbiome market has been segmented into:

  • Gastrointestinal Tract Human Micobiome
  • Urogenital Tract Human Micobiome
  • Other

By Application, Human Microbiome has been segmented into:
  • Treatment
  • Diagnosis

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Microbiome market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Microbiome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Microbiome market.

The report offers in-depth assessment of the growth and other aspects of the Human Microbiome market in important countries (regions), including:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Microbiome Market Share Analysis
Human Microbiome competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Microbiome sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Microbiome sales, revenue and market share for each player covered in this report.

The major players covered in Human Microbiome are:
  • Vedanta
  • 4D Pharma Research Ltd
  • Rebiotix
  • Seres Therapeutics
  • AvidBiotics
  • Second Genome
  • Metabogen
  • Enterome BioScience
  • ActoGeniX
  • Enterologics
  • Miomics
  • Metabiomics
  • Symbiotix Biotherapies
  • Symberix
  • Ritter Pharmaceuticals
  • MicroBiome Therapeutics LLC
  • Osel

Among other players domestic and global, Human Microbiome market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately.

There are 14 Chapters to deeply display the global Human Microbiome market.
1 Human Microbiome Market Overview
2 Company Profiles
3 Global Human Microbiome Market Competition, by Players
4 Global Human Microbiome Market Size by Regions
5 North America Human Microbiome Revenue by Countries
6 Europe Human Microbiome Revenue by Countries
7 Asia-Pacific Human Microbiome Revenue by Countries
8 South America Human Microbiome Revenue by Countries
9 Middle East and Africa Revenue Human Microbiome by Countries
10 Global Human Microbiome Market Segment by Type
11 Global Human Microbiome Market Segment by Application
12 Global Human Microbiome Market Size Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix

Table of Contents
 
1 Human Microbiome Market Overview
1.1 Product Overview and Scope of Human Microbiome
1.2 Classification of Human Microbiome by Type
1.2.1 Global Human Microbiome Revenue by Type
1.2.2 Global Human Microbiome Revenue Market Share by Type in 2019
1.2.3 Gastrointestinal Tract Human Micobiome
1.2.4 Urogenital Tract Human Micobiome
1.2.5 Other
1.3 Global Human Microbiome Market by Application
1.3.1 Overview: Global Human Microbiome Revenue by Application
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Global Human Microbiome Market by Regions
1.4.1 Global Human Microbiome Market Size by Regions
1.4.2 Global Market Size of Human Microbiome (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Microbiome Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Microbiome Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Microbiome Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Microbiome Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Microbiome Status and Prospect (2015-2025)
2 Company Profiles
2.1 Vedanta
2.1.1 Vedanta Details
2.1.2 Vedanta Major Business
2.1.3 Vedanta SWOT Analysis
2.1.4 Vedanta Product and Services
2.1.5 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.2 4D Pharma Research Ltd
2.2.1 4D Pharma Research Ltd Details
2.2.2 4D Pharma Research Ltd Major Business
2.2.3 4D Pharma Research Ltd SWOT Analysis
2.2.4 4D Pharma Research Ltd Product and Services
2.2.5 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.3 Rebiotix
2.3.1 Rebiotix Details
2.3.2 Rebiotix Major Business
2.3.3 Rebiotix SWOT Analysis
2.3.4 Rebiotix Product and Services
2.3.5 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.4 Seres Therapeutics
2.4.1 Seres Therapeutics Details
2.4.2 Seres Therapeutics Major Business
2.4.3 Seres Therapeutics SWOT Analysis
2.4.4 Seres Therapeutics Product and Services
2.4.5 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.5 AvidBiotics
2.5.1 AvidBiotics Details
2.5.2 AvidBiotics Major Business
2.5.3 AvidBiotics SWOT Analysis
2.5.4 AvidBiotics Product and Services
2.5.5 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.6 Second Genome
2.6.1 Second Genome Details
2.6.2 Second Genome Major Business
2.6.3 Second Genome Product and Services
2.6.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.7 Metabogen
2.7.1 Metabogen Details
2.7.2 Metabogen Major Business
2.7.3 Metabogen Product and Services
2.7.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.8 Enterome BioScience
2.8.1 Enterome BioScience Details
2.8.2 Enterome BioScience Major Business
2.8.3 Enterome BioScience Product and Services
2.8.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.9 ActoGeniX
2.9.1 ActoGeniX Details
2.9.2 ActoGeniX Major Business
2.9.3 ActoGeniX Product and Services
2.9.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.10 Enterologics
2.10.1 Enterologics Details
2.10.2 Enterologics Major Business
2.10.3 Enterologics Product and Services
2.10.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.11 Miomics
2.11.1 Miomics Details
2.11.2 Miomics Major Business
2.11.3 Miomics Product and Services
2.11.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.12 Metabiomics
2.12.1 Metabiomics Details
2.12.2 Metabiomics Major Business
2.12.3 Metabiomics Product and Services
2.12.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.13 Symbiotix Biotherapies
2.13.1 Symbiotix Biotherapies Details
2.13.2 Symbiotix Biotherapies Major Business
2.13.3 Symbiotix Biotherapies Product and Services
2.13.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.14 Symberix
2.14.1 Symberix Details
2.14.2 Symberix Major Business
2.14.3 Symberix Product and Services
2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ritter Pharmaceuticals
2.15.1 Ritter Pharmaceuticals Details
2.15.2 Ritter Pharmaceuticals Major Business
2.15.3 Ritter Pharmaceuticals Product and Services
2.15.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.16 MicroBiome Therapeutics LLC
2.16.1 MicroBiome Therapeutics LLC Details
2.16.2 MicroBiome Therapeutics LLC Major Business
2.16.3 MicroBiome Therapeutics LLC Product and Services
2.16.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.17 Osel
2.17.1 Osel Details
2.17.2 Osel Major Business
2.17.3 Osel Product and Services
2.17.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Microbiome Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Microbiome Players Market Share
3.2.2 Top 10 Human Microbiome Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Microbiome Revenue and Market Share by Regions
4.2 North America Human Microbiome Revenue and Growth Rate (2015-2020)
4.3 Europe Human Microbiome Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Microbiome Revenue and Growth Rate (2015-2020)
4.5 South America Human Microbiome Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Microbiome Revenue and Growth Rate (2015-2020)
5 North America Human Microbiome Revenue by Countries
5.1 North America Human Microbiome Revenue by Countries (2015-2020)
5.2 USA Human Microbiome Revenue and Growth Rate (2015-2020)
5.3 Canada Human Microbiome Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Microbiome Revenue and Growth Rate (2015-2020)
6 Europe Human Microbiome Revenue by Countries
6.1 Europe Human Microbiome Revenue by Countries (2015-2020)
6.2 Germany Human Microbiome Revenue and Growth Rate (2015-2020)
6.3 UK Human Microbiome Revenue and Growth Rate (2015-2020)
6.4 France Human Microbiome Revenue and Growth Rate (2015-2020)
6.5 Russia Human Microbiome Revenue and Growth Rate (2015-2020)
6.6 Italy Human Microbiome Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Microbiome Revenue by Countries
7.1 Asia-Pacific Human Microbiome Revenue by Countries (2015-2020)
7.2 China Human Microbiome Revenue and Growth Rate (2015-2020)
7.3 Japan Human Microbiome Revenue and Growth Rate (2015-2020)
7.4 Korea Human Microbiome Revenue and Growth Rate (2015-2020)
7.5 India Human Microbiome Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Microbiome Revenue and Growth Rate (2015-2020)
8 South America Human Microbiome Revenue by Countries
8.1 South America Human Microbiome Revenue by Countries (2015-2020)
8.2 Brazil Human Microbiome Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Microbiome Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Microbiome by Countries
9.1 Middle East & Africa Human Microbiome Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Microbiome Revenue and Growth Rate (2015-2020)
9.3 UAE Human Microbiome Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Microbiome Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Microbiome Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Microbiome Revenue and Market Share by Type (2015-2020)
10.2 Global Human Microbiome Market Forecast by Type (2019-2024)
10.3 Gastrointestinal Tract Human Micobiome Revenue Growth Rate (2015-2025)
10.4 Urogenital Tract Human Micobiome Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Human Microbiome Market Segment by Application
11.1 Global Human Microbiome Revenue Market Share by Application (2015-2020)
11.2 Human Microbiome Market Forecast by Application (2019-2024)
11.3 Treatment Revenue Growth (2015-2020)
11.4 Diagnosis Revenue Growth (2015-2020)
12 Global Human Microbiome Market Size Forecast (2021-2025)
12.1 Global Human Microbiome Market Size Forecast (2021-2025)
12.2 Global Human Microbiome Market Forecast by Regions (2021-2025)
12.3 North America Human Microbiome Revenue Market Forecast (2021-2025)
12.4 Europe Human Microbiome Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Microbiome Revenue Market Forecast (2021-2025)
12.6 South America Human Microbiome Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Microbiome Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Related Categories
Life Sciences
Related Reports
Global ERCP Market Research Report 2016

DecisionDatabases.com offers an introspective view of the industry in the report “Global ERCP Market Research Report 2016”. The market  read more..


Global Balloon Dilator Market Research Report 2017

The Global Balloon Dilator Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global HIV Testing Market Research Report 2016

DecisionDatabases.com offers an introspective view of the industry in the report “Global HIV Testing Market Research Report 2016”. The market  read more..


Global Blood Banking Market Research Report 2016

DecisionDatabases.com offers an introspective view of the industry in the report “Global Blood Banking Market Research Report 2016”. The  read more..


Global Chimeric Antibody Market Insights, Forecast to 2025

Chimeric Antibody Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Japan Gout Drugs Market Report 2016

DecisionDatabases.com offers an introspective view of the industry in the report “Japan Gout Drugs Market Report 2016”. The market dynamics  read more..


Global Flow Cytometry Consumption 2016 Market Research Report

The market research report on Flow Cytometry Consumption market offered by DecisionDatabases.com provides an introspective view of the industry including  read more..


Global Hot Surface Igniters Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Hot Surface Igniters Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Botox Sales Market Report 2018-2025

The Global Botox Sales market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and  read more..


Global Pulse Oximter Industry 2016 Market Research Report

The Global Pulse Oximter Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Pulse Oximter  read more..